AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2015
Apr 30, 2015
29755_dirs_2015-04-30_37de802f-8c86-4c61-bf5b-85b4fb34d253.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-04-28
Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-28 | Common stock, $0.01 par value | M | 175477 | $35.88 | Acquired | 657624 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 1800 | $64.5 | Disposed | 655824 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 800 | $64.52 | Disposed | 655024 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 400 | $64.53 | Disposed | 654624 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 2100 | $64.56 | Disposed | 652524 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 1300 | $64.57 | Disposed | 651224 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 300 | $64.58 | Disposed | 650924 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 800 | $64.59 | Disposed | 650124 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 5600 | $64.6 | Disposed | 644524 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 3548 | $64.61 | Disposed | 640976 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 900 | $64.62 | Disposed | 640076 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 3000 | $64.64 | Disposed | 637076 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 8100 | $64.65 | Disposed | 628976 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 200 | $64.655 | Disposed | 628776 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 3800 | $64.66 | Disposed | 624976 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 2500 | $64.67 | Disposed | 622476 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 4317 | $64.68 | Disposed | 618159 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 1805 | $64.685 | Disposed | 616354 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 3200 | $64.69 | Disposed | 613154 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 400 | $64.695 | Disposed | 612754 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 34900 | $64.7 | Disposed | 577854 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 1100 | $64.705 | Disposed | 576754 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 8100 | $64.71 | Disposed | 568654 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 300 | $64.715 | Disposed | 568354 | Direct |
| 2015-04-08 | Common stock, $0.01 par value | S | 6994 | $64.72 | Disposed | 561360 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 1400 | $64.725 | Disposed | 559960 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 4000 | $64.73 | Disposed | 555960 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 900 | $64.735 | Disposed | 555060 | Direct |
| 2015-04-28 | Common stock, $0.01 par value | S | 400 | $64.7375 | Disposed | 554660 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-28 | Option (right to buy) | $35.88 | M | 175477 | Disposed | 2023-02-13 | Common stock (175477) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4